Skip to main content
Clinical Trials/NCT03973814
NCT03973814CompletedNot Applicable

Hypothermia Risk With Continuous Renal Replacement Therapy

Karolinska University Hospital2 sites in 1 country100 target enrollmentStarted: August 1, 2022Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
100
Locations
2
Primary Endpoint
Temperature, accuracy

Study Overview

Brief Summary

The present study aims at testing if the TherMax blood warmer is more accurate and reliable in reaching and maintaining chosen target temperature during continuous renal replacement therapy as compared to the Prismaflo IIS blood warmer used for the PrismaFlex system.

Detailed Description

Blood warming devices during continuous renal replacement therapy (CRRT) have not been adequately tested.

The novel TherMax blood warmer for the newly introduced PrisMax System heats blood and replacement solutions via a dry heat plate system. In contrast, the PRISMAFLO IIS Blood Warmer for PRISMAFLEX System uses an electric heating sleeve on a standard CRRT filter set.

Data on adverse events (AE) during continuous renal replacement therapy (CRRT) has been studied and one of the most common AE was hypothermia, reported in 44% of all cases.

The present study aims at testing if the TherMax blood warmer is more accurate and reliable in reaching and maintaining chosen target temperature during CRRT as compared to the blood warmer used for the PrismaFlex system.

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Sequential
Primary Purpose
Supportive Care
Masking
None

Eligibility Criteria

Ages
18 Years to 100 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Adult (18-100 years) critically ill patients treated with CRRT.

Exclusion Criteria

  • Patients under 18 years of age. Non-RRT patients.

Outcomes

Primary Outcomes

Temperature, accuracy

Time Frame: 24 hours

During use of Thermax; hourly difference between prescribed temperature-measured temperature; accuracy 0,1 Celsius

Secondary Outcomes

  • Temperature, differences(12-18 hours (six hour warming period))
  • Historic comparator(24 hours)

Investigators

Sponsor
Karolinska University Hospital
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Max Bell

MD, PhD, Principal Investigator

Karolinska University Hospital

Study Sites (2)

Loading locations...

Similar Trials